Phase 2 Study of Quizartinib in Participants With Acute Myeloid Leukemia (AML) FLT3 Internal Tandem Duplication (FLT3/ITD) Mutation
Clinical trial NCT02984995 · COMPLETED
Trial details
- NCT number
- NCT02984995
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-08
- Primary completion
- 2018-03-28
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.